Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Koh

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 17, 2010
[Recent development of novel reverse transcriptase inhibitors and protease inhibitors against HIV-1 infection]Yasuhiro Koh
The Japanese Journal of Antibiotics|June 20, 2013
[Study of HIV protease dimerization (PD) and identification of novel PD inhibitors (PDIs)]Yasuhiro Koh
Immunotherapy|April 23, 2020
Tumor immune microenvironment of <i>EGFR</i>-mutant non-small-cell lung cancer and its impact on therapeutic efficacyYoshiya Matsumoto, Yasuhiro Koh
Journal of Virology|January 27, 2012
Correlation of recombinant integrase activity and functional preintegration complex formation during acute infection by replication-defective integrase mutant human immunodeficiency virusXiang Li, Yasuhiro Koh, Alan Engelman
Seikagaku. the Journal of Japanese Biochemical Society|May 20, 2016
[A novel flow cytometry-based cell capture platform for the detection, capture and molecular characterization of rare tumor cells in blood]Masaru Watanabe, Yasuhiro Koh, Nobuyuki Yamamoto
Antimicrobial Agents and Chemotherapy|November 10, 2010
Identification and characterization of persistent intracellular human immunodeficiency virus type 1 integrase strand transfer inhibitor activityYasuhiro Koh, Hillel Haim, Alan Engelman
Journal of Virology|January 29, 2011
Differential sensitivities of retroviruses to integrase strand transfer inhibitorsYasuhiro Koh, Kenneth A Matreyek, Alan Engelman
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 22, 2013
Combined treatment with erlotinib and a transforming growth factor-β type I receptor inhibitor effectively suppresses the enhanced motility of erlotinib-resistant non-small-cell lung cancer cellsMasakuni Serizawa, Toshiaki Takahashi, Nobuyuki Yamamoto, et al.
AIDS (London, England)|February 1, 2013
Polymorphic LEDGF/p75 variants support efficient HIV-1 infection ex vivoYasuhiro Koh, Ester Ballana, José Este, et al.
Anticancer Research|December 11, 2013
Genomic aberrations associated with erlotinib resistance in non-small cell lung cancer cellsMasakuni Serizawa, Toshiaki Takahashi, Nobuyuki Yamamoto, et al.
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 17, 2010
[Recent development of novel reverse transcriptase inhibitors and protease inhibitors against HIV-1 infection]Yasuhiro Koh
The Japanese Journal of Antibiotics|June 20, 2013
[Study of HIV protease dimerization (PD) and identification of novel PD inhibitors (PDIs)]Yasuhiro Koh
Immunotherapy|April 23, 2020
Tumor immune microenvironment of <i>EGFR</i>-mutant non-small-cell lung cancer and its impact on therapeutic efficacyYoshiya Matsumoto, Yasuhiro Koh
Journal of Virology|January 27, 2012
Correlation of recombinant integrase activity and functional preintegration complex formation during acute infection by replication-defective integrase mutant human immunodeficiency virusXiang Li, Yasuhiro Koh, Alan Engelman
Seikagaku. the Journal of Japanese Biochemical Society|May 20, 2016
[A novel flow cytometry-based cell capture platform for the detection, capture and molecular characterization of rare tumor cells in blood]Masaru Watanabe, Yasuhiro Koh, Nobuyuki Yamamoto
Antimicrobial Agents and Chemotherapy|November 10, 2010
Identification and characterization of persistent intracellular human immunodeficiency virus type 1 integrase strand transfer inhibitor activityYasuhiro Koh, Hillel Haim, Alan Engelman
Journal of Virology|January 29, 2011
Differential sensitivities of retroviruses to integrase strand transfer inhibitorsYasuhiro Koh, Kenneth A Matreyek, Alan Engelman
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 22, 2013
Combined treatment with erlotinib and a transforming growth factor-β type I receptor inhibitor effectively suppresses the enhanced motility of erlotinib-resistant non-small-cell lung cancer cellsMasakuni Serizawa, Toshiaki Takahashi, Nobuyuki Yamamoto, et al.
AIDS (London, England)|February 1, 2013
Polymorphic LEDGF/p75 variants support efficient HIV-1 infection ex vivoYasuhiro Koh, Ester Ballana, José Este, et al.
Anticancer Research|December 11, 2013
Genomic aberrations associated with erlotinib resistance in non-small cell lung cancer cellsMasakuni Serizawa, Toshiaki Takahashi, Nobuyuki Yamamoto, et al.
Pageof 15